CLL cells express low levels of SLea/x [141,142]; despite the presence of different potential E-selectin ligand scaffolds, such as CD43, CD44, and L-selectin, binding to E-selectin should be severely compromised. The gene discussed is SELL; the disease is B-cell chronic lymphocytic leukemia.